We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$84.7B
AUM Growth
+$3.15B
Cap. Flow
-$3.2B
Cap. Flow %
-3.77%
Top 10 Hldgs %
10.93%
Holding
2,264
New
35
Increased
617
Reduced
853
Closed
525

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$128M
2
DHR icon
Danaher
DHR
+$114M
3
ZBRA icon
Zebra Technologies
ZBRA
+$112M
4
AIZ icon
Assurant
AIZ
+$92.7M
5
EXC icon
Exelon
EXC
+$92.2M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$189M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$143M
3
MRK icon
Merck
MRK
+$136M
4
ABMD
Abiomed Inc
ABMD
+$124M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$124M

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Healthcare 15.17%
3 Financials 13.51%
4 Industrials 10.72%
5 Consumer Discretionary 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPD icon
1301
Enterprise Products Partners
EPD
$82.5B
$1.32M ﹤0.01%
54,728
-218,927
-80% -$5.39M
HVT icon
1302
Haverty Furniture Companies
HVT
$406M
$1.31M ﹤0.01%
43,900
-1,421
-3% -$41.5K
NX icon
1303
Quanex
NX
$863M
$1.3M ﹤0.01%
54,980
– –
HBAN icon
1304
Huntington Bancshares
HBAN
$34.7B
$1.3M ﹤0.01%
92,019
– –
UAL icon
1305
United Airlines
UAL
$39.1B
$1.3M ﹤0.01%
34,400
– –
CDP icon
1306
COPT Defense Properties
CDP
$4.34B
$1.3M ﹤0.01%
49,958
-3,624
-7% -$93.2K
KPTI icon
1307
Karyopharm Therapeutics
KPTI
$161M
$1.29M ﹤0.01%
25,333
-98
-0.4% -$6.79K
ETRN
1308
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$1.27M ﹤0.01%
189,063
+48,044
+34% +$373K
FSTA icon
1309
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
$1.27M ﹤0.01%
28,243
– –
VIRT icon
1310
Virtu Financial
VIRT
$5.12B
$1.26M ﹤0.01%
61,723
-20,223
-25% -$439K
LYV icon
1311
Live Nation Entertainment
LYV
$41.7B
$1.26M ﹤0.01%
18,058
-3,356
-16% -$249K
LNC icon
1312
Lincoln National
LNC
$7.88B
$1.26M ﹤0.01%
40,990
+759
+2% +$30.1K
SGMO
1313
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.26M ﹤0.01%
400,000
-260
-0.1% -$1.01K
TKR icon
1314
Timken Company
TKR
$9.81B
$1.24M ﹤0.01%
17,600
-20,118
-53% -$1.41M
FCOM icon
1315
Fidelity MSCI Communication Services Index ETF
FCOM
$1.77B
$1.22M ﹤0.01%
39,263
– –
ABCL icon
1316
AbCellera Biologics
ABCL
$1.6B
$1.21M ﹤0.01%
+119,399
New +$1.38M
THO icon
1317
Thor Industries
THO
$3.98B
$1.21M ﹤0.01%
16,024
+14,029
+703% +$1.13M
KSS icon
1318
Kohl's
KSS
$2.1B
$1.21M ﹤0.01%
47,900
-1,726
-3% -$48.9K
FDS icon
1319
Factset
FDS
$9.46B
$1.2M ﹤0.01%
2,990
-524
-15% -$223K
CDMO
1320
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1.19M ﹤0.01%
86,340
-26,847
-24% -$411K
NMFC icon
1321
New Mountain Finance
NMFC
$649M
$1.18M ﹤0.01%
95,300
– –
HWM icon
1322
Howmet Aerospace
HWM
$115B
$1.16M ﹤0.01%
29,546
-8,602
-23% -$314K
WTFC icon
1323
Wintrust Financial
WTFC
$10.7B
$1.16M ﹤0.01%
13,715
+13,105
+2,148% +$1.16M
FBP icon
1324
First Bancorp
FBP
$4.39B
$1.14M ﹤0.01%
89,200
– –
RCKT icon
1325
Rocket Pharmaceuticals
RCKT
$355M
$1.14M ﹤0.01%
58,000
-317
-0.5% -$5.84K
51 52
53
54 55

Similar funds

AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Macquarie Group's Q4 2022 Portfolio in Review

As of Q4 2022, Macquarie Group held 2,264 positions worth $84.7B, up 3.9% from $81.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.2B in Q4 2022, closing 525 positions and reducing 853 holdings. Its most notable exit was Abiomed Inc, an estimated $124M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in iShares 0-5 Year Investment Grade Corporate Bond ETF worth $58.3M.

  • Macquarie Group's largest Q4 2022 buy was iShares 0-5 Year Investment Grade Corporate Bond ETF: 1,218,670 shares worth $58.3M.
  • Macquarie Group added most to L3Harris in Q4 2022, an estimated $128M increase.
  • Macquarie Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $189M.
  • Macquarie Group fully exited Abiomed Inc in Q4 2022, selling an estimated $124M.
  • Macquarie Group's ten largest holdings make up 11% of its $84.7B portfolio in Q4 2022.
  • Macquarie Group opened 35 new positions and closed 525 in Q4 2022.
  • Macquarie Group's portfolio value rose 3.9% quarter-over-quarter to $84.7B.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.